Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy-Reference-Cited by-同舟云学术

Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy

Published:2022-12-20 Issue:2 Volume:12 Page:827-837
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Zhou Huiying,Zhao Xinyu,Wang Shuran,Chen Youxin^ORCID

Funder

Natural Science Foundation of Beijing Municipality

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-022-00618-4.pdf

Reference36 articles.

1. Bobadilla M, Pariente A, Oca AI, Pelaez R, Perez-Sala A, Larrayoz IM. Biomarkers as predictive factors of anti-VEGF response. Biomedicines. 2022;10(5):1003.

2. Fursova AZ, Derbeneva AS, Vasilyeva MS, et al. New findings on pathogenetic mechanisms in the development of age-related macular degeneration. Vestn Oftalmol. 2022;138(2):120–30.

3. Sahu Y, Chaudhary N, Joshi M, Gandhi A. Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices. Int Ophthalmol. 2021;41(2):753–65.

4. Kim S, Min G, Kim B, et al. Novel dual-targeting antibody fragment IDB0062 overcomes anti-vascular endothelial growth factor drug limitations in age-related macular degeneration. Transl Vis Sci Technol. 2021;10(14):35.

5. Cho HJ, Park SM, Kim J, et al. Progression of macular atrophy in patients undergoing anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Acta Ophthalmol. 2021;99(4):e540–6.